Publications by authors named "Bruce Mungall"

Claim this Profile
I
In Vitro Antiviral Screening for Henipaviruses at BSL4.
Bruce A Mungall

Methods Mol Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter to the editor on a systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.
Bruce A Mungall, Bernard Hoet, Javier Nieto Guevara, Lamine Soumahoro

Expert Rev Vaccines· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines.
Eleanor Bell, Simon Brassel, Edward Oliver, Hannah Schirrmacher, Sofie Arnetorp, Bruce Mungall

Vaccines (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.
Bruce A Mungall, Bernard Hoet, Javier Nieto Guevara, Lamine Soumahoro

Expert Rev Vaccines· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the burden of pertussis in South Korea.
Bruce A Mungall, Hyungwoo Kim, Kyu-Bin Oh

Hum Vaccin Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten years of experience with the pneumococcal non-typeable protein D-conjugate vaccine () in children.
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Lamine Soumahoro, Javier Nieto Guevara, Bruce Mungall

Expert Rev Vaccines· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor to: Isturiz et al. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007-27.
Bruce A Mungall, Javier Nieto, Lamine Soumahoro, Bernard Hoet

Expert Rev Vaccines· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.
Lijoy Varghese, Louise Talbot, Andrea Govender, Xu-Hao Zhang, Bruce A Mungall

Appl Health Econ Health Policy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.
Lance Jennings, Qiu Sue Huang, Ian Barr, Ping-Ing Lee, Woo Joo Kim, Bruce A Mungall

Influenza Other Respir Viruses· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong.
Lijoy Varghese, Bruce Mungall, Xu-Hao Zhang, Bernard Hoet

Hum Vaccin Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-hepatitis B activity of isoquinoline alkaloids of plant origin.
Mohamad Aljofan, Hans J Netter, Ahmed N Aljarbou, Taibi Ben Hadda, Ilkay Erdogan Orhan, Bruce A Mungall

Arch Virol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors.
Matthew Brudner, Marshall Karpel, Calli Lear, Li Chen, L Michael Yantosca, Bruce A Mungall

PLoS One· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus.
Ian C Michelow, Mingdong Dong, Bruce A Mungall, L Michael Yantosca, Calli Lear

J Biol Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons.
Michael K Lo, David Miller, Mohammad Aljofan, Bruce A Mungall, Pierre E Rollin

Virology· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral entry inhibitors targeted to the membrane site of action.
Matteo Porotto, Christine C Yokoyama, Laura M Palermo, Bruce Mungall, Mohamad Aljofan

J Virol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.
Mohamad Aljofan, Michael K Lo, Paul A Rota, Wojtek P Michalski, Bruce A Mungall

J Antivir Antiretrovir· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.
Mohamad Aljofan, Michael L Sganga, Michael K Lo, Christina L Rootes, Matteo Porotto, Bruce A Mungall

Virol J· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic dependence of paramyxovirus entry inhibition.
Matteo Porotto, Christine C Yokoyama, Gianmarco Orefice, Han-Sung Kim, Mohamed Aljofan, Bruce A Mungall

J Virol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.
Laura M Palermo, Matteo Porotto, Christine C Yokoyama, Samantha G Palmer, Bruce A Mungall

J Virol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening.
Mohamad Aljofan, Simon Saubern, Adam G Meyer, Glenn Marsh, Joanne Meers, Bruce A Mungall

Virus Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
Matteo Porotto, Gianmarco Orefice, Christine C Yokoyama, Bruce A Mungall, Ronald Realubit

J Virol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells.
Michael K Lo, Brian H Harcourt, Bruce A Mungall, Azaibi Tamin, Mark E Peeples

J Gen Virol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Henipavirus infection by RNA interference.
Bruce A Mungall, Nick C T Schopman, Luke S Lambeth, Tim J Doran

Antiviral Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus.
Mohamad Aljofan, Matteo Porotto, Anne Moscona, Bruce A Mungall

J Virol Methods· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Henipavirus susceptibility to environmental variables.
Rhys Fogarty, Kim Halpin, Alex D Hyatt, Peter Daszak, Bruce A Mungall

Virus Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis